Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 77,767 | 75,804 | 88,123 | 122,238 | 146,254 |
| Cost of Goods | 24,290 | 18,477 | 28,715 | 46,489 | 76,776 |
| Gross Profit | 53,477 | 57,327 | 59,408 | 75,749 | 69,478 |
| Operating Expenses | 169,952 | 175,501 | 78,956 | 95,573 | 28,367 |
| Operating Income | -116,185 | -117,697 | -18,833 | -19,335 | 41,887 |
| Interest Expense | 6,330 | 6,450 | 6,572 | 13,366 | 16,056 |
| Other Income | 1,226 | 1,926 | 2,110 | -34,329 | 908 |
| Pre-tax Income | -121,289 | -122,221 | -23,295 | -67,030 | 26,739 |
| Income Tax | -120 | -137 | -2,550 | -2,352 | 52,556 |
| Net Income Continuous | -121,169 | -122,084 | -20,745 | -64,678 | -25,817 |
| Net Income Discontinuous | N/A | N/A | -1,532 | 95,517 | 5,736 |
| Net Income | $-121,169 | $-122,084 | $-22,277 | $30,839 | $-20,081 |
| EPS Basic Total Ops | -3.58 | -3.54 | -0.63 | 0.89 | -0.58 |
| EPS Basic Continuous Ops | -3.58 | -3.54 | -0.59 | -1.88 | -0.75 |
| EPS Basic Discontinuous Ops | N/A | N/A | -0.04 | 2.77 | 0.17 |
| EPS Diluted Total Ops | -3.58 | -3.54 | -0.63 | 0.89 | -0.58 |
| EPS Diluted Continuous Ops | -3.58 | -3.54 | -0.59 | -1.88 | -0.75 |
| EPS Diluted Discontinuous Ops | N/A | N/A | -0.04 | 2.77 | 0.17 |
| EPS Diluted Before Non-Recurring Items | -1.28 | -3.32 | -0.60 | N/A | N/A |
| EBITDA(a) | $-107,765 | $-109,566 | $-787 | $16,460 | $112,582 |